SCHEMBL7979447

SCHEMBL7979447

N=C(NCc1ccccc1Cl)c1ccc2ccccc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 1/20 0.51
GRIN2B Q13224 1/20 0.51
NPC1 O15118 3/20 0.49
RAB9A P51151 2/20 0.49
SMN1; SMN2 Q16637 1/20 0.47
TP53 P04637 2/20 0.45
F2 P00734 1/20 0.44
PLG P00747 1/20 0.44
PLAU P00749 1/20 0.44
KLKB1 P03952 1/20 0.44
KLK1 P06870 1/20 0.44
PRSS1 P07477 1/20 0.44
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 2/20 0.42
HTT P42858 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7412370 0.79 HPGD (0.54) GRIN1GRIN2BNPC1RAB9ASMN1; SMN2
SCHEMBL3583496 0.79 NPC1 (0.51) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL31622512 0.74 HDAC3 (0.58) GRIN1GRIN2BNPC1RAB9ASMN1; SMN2
SCHEMBL26106538 0.74 SMN1; SMN2 (0.51) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL26108291 0.74 SMN1; SMN2 (0.45) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL3030085 0.73 HDAC8 (0.61) NPC1RAB9ASMN1; SMN2TP53ALDH1A1
SCHEMBL5068038 0.71 NPC1 (0.61) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL4023664 0.71 NPC1 (0.61) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL15928202 0.71 NPC1 (0.61) NPC1RAB9ASMN1; SMN2TP53MEN1
SCHEMBL1821001 0.70 PLG (0.59) SMN1; SMN2TP53F2PLGPLAU

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6319944-B1 NMDA NR2B ANTAGONISTS; NEUROLOGICAL AND NEURODEGENERATIVE DISEASES INCLUDING PAIN, (AND IN PARTICULAR NEUROPATHIC PAIN), EPILEPSY, STROKE, ANXIETY, CEREBRAL ISCHEMIA, MUSCULAR SPASMS, ALZHEIMER'S, HUNTINGTON'S AND PARKINSON'S DISEASES MERCK & CO., INC. 2001-11-20 US claimed
US-6319944-B1 NMDA NR2B ANTAGONISTS; NEUROLOGICAL AND NEURODEGENERATIVE DISEASES INCLUDING PAIN, (AND IN PARTICULAR NEUROPATHIC PAIN), EPILEPSY, STROKE, ANXIETY, CEREBRAL ISCHEMIA, MUSCULAR SPASMS, ALZHEIMER'S, HUNTINGTON'S AND PARKINSON'S DISEASES MERCK & CO., INC. 2001-11-20 US disclosed